Abstract
A 70-year-old female presented with complaints of gradual blurring OU for 2 months. Her vision dropped from 6/6 to 6/20 in the right eye and from 6/12 to 6/60 in the left within 2 months. According to her family, her medical history included hypertension, cardiac arrhythmia, and controlled hypothyroidism under Eltroxin. She was diagnosed with pulmonary tuberculosis 11 months prior and has since been taking AkuriT-3 (Rifampin 150 mg), isoniazid (75 mg), and ethambutol (275 mg) 4# QD. These medications were discontinued 9 months ago and changed to PZA (500 mg) 3# QD. PZA was used for half a year and was changed to Rifinah (300 mg) 2#QD for 3 weeks and again changed to Levofloxacin (500 mg) 1# QD and Rifampin (150 mg) 4# QD. Her vision notably worsened in the most recent 2 months, despite active revision of antituberculosis medications, so she was referred to our department.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Wang MY, Sadun AA. Drug-related mitochondrial optic neuropathies. J Neuroophthalmol. 2013;33(2):172–8.
Kozak SF, Inderlied CB, Hsu HY, Heller KB, Sadun AA. The role of copper on ethambutol’s antimicrobial action and implications for ethambutol-induced optic neuropathy. Diagn Microbiol Infect Dis. 1998;30:83–7.
Santaella RM, Fraunfelder FW. Ocular adverse effects associated with systemic medications: recognition and management. Drugs. 2007;67:75–93.
Lloyd MJ, Fraunfelder FW. Drug-induced optic neuropathies. Drugs Today (Barc). 2007;43:827–36.
Barron GJ, Tepper L, Iovine G. Ocular toxicity from ethambutol. Am J Ophthalmol. 1974;77:256–60.
Citron KM, Thomas GO. Ocular toxicity from ethambutol. Thorax. 1986;41:737–9.
Chan RY, Kwok AK. Ocular toxicity of ethambutol. Hong Kong Med J. 2006;12(1):56–60.
Kumar A, Sandramouli S, Verma L, Tewari HK, Khosla PK. Ocular ethambutol toxicity: is it reversible? J Clin Neuroophthalmol. 1993;13:15–7.
Chatterjee VK, Buchanan DR, Friedmann AI, Green M. Ocular toxicity following ethambutol in standard dosage. Br J Dis Chest. 1986;80:288–91.
Schild HS, Fox BC. Rapid-onset reversible ocular toxicity from ethambutol therapy. Am J Med. 1991;90:404–6.
Asayama T. Two cases of bitemporal hemianopsia due to ethambutol. Jpn J Clin Ophthalmol. 1969;23:1209–12.
Kho RC, Al-Obailan M, Arnold AC. Bitemporal visual field defects in ethambutol-induced optic neuropathy. J Neuroophthalmol. 2011;31:121–6.
Lee EJ, Kim SJ, Choung HK, Kim JH, Yu YS. Incidence and clinical features of ethambutol-induced optic neuropathy in Korea. J Neuroophthalmol. 2008;28(4):269–77.
Sivakumaran P, Harrison AC, Marschner J, Martin P. Ocular toxicity from ethambutol: a review of 4 cases and recommended precautions. N Z Med J. 1998;111:428–30.
Tsai RK, Lee YH. Reversibility of ethambutol optic neuropathy. J Ocul Pharmacol Ther. 1997;13:473–7.
Woung LC, Jou JR, Liaw SL. Visual function in recovered ethambutol optic neuropathy. J Ocul Pharmacol Ther. 1995;11:411–9.
Chen SC, Lin MC, Sheu SJ. Incidence and prognostic factor of ethambutol-related optic neuropathy: 10-year experience in southern Taiwan. Kaohsiung J Med Sci. 2015;31(7):358–62.
Chuenkongkaew W, Samsen P, Thanasombatsakul N. Ethambutol and optic neuropathy. J Med Assoc Thai. 2003;86:622–5.
Sadun AA, Wang MY. Ethambutol optic neuropathy: how we can prevent 100,000 new cases of blindness each year. J Neuroophthalmol. 2008;28:265–8.
Chen HY, Lai SW, Muo CH, et al. Ethambutol-induced optic neuropathy: a nationwide population-based study from Taiwan. Br J Ophthalmol. 2012;96:1368–137.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Wang, AG. (2018). Ethambutol-Induced Optic Neuropathy. In: Emergency Neuro-ophthalmology . Springer, Singapore. https://doi.org/10.1007/978-981-10-7668-8_11
Download citation
DOI: https://doi.org/10.1007/978-981-10-7668-8_11
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-7667-1
Online ISBN: 978-981-10-7668-8
eBook Packages: MedicineMedicine (R0)